Excessive peroxidation of biomembranes is thought to contribute to the initiation and progression of numerous degenerative diseases. The present study examined the inhibitory effects of a cocoa extract, individual cocoa flavanols (-)-epicatechin and (+)-catechin, and procyanidin oligomers (dimer to decamer) isolated from cocoa on rat erythrocyte hemolysis. In vitro, the flavanols and the procyanidin oligomers exhibited dose-dependent protection against 2,2'-azo-bis (2-amidinopropane) dihydrochloride (AAPH)-induced erythrocyte hemolysis between concentrations of 2.5 and 40 μM. Dimer, trimer, and tetramer showed the strongest inhibitory effects at 10 μM, 59.4%, 66.2%, 70.9%; 20 μM, 84.1%, 87.6%, 81.0%; and 40 μM, 90.2%, 88.9%, 78-6%, respectively. In a subsequent experiment, male Sprague-Dawley rats (~200 g; n = 5-6) were given a 100-mg intragastric dose of a cocoa extract. Blood was collected over a 4-hr time period. Epicatechin and catechin, and the dimers (-)-epicatechin-(4β>8)-epicatechin (Dimer B2) and (-)-epicatechin-(4β<6)-epicatechin (Dimer B5) were detected in the plasma with concentrations of 6.4 μM, and 217.6, 248.2, and 55.4 nM, respectively. Plasma antioxidant capacity (as measured by the total antioxidant potential [TRAP] assay) was elevated (P < 0.05) between 30 and 240 min following the cocoa extract feeding. Erythrocytes obtained from the cocoa extract-fed animals showed an enhanced resistance to hemolysis (P < 0.05). This enhanced resistance was also observed when erythrocytes from animals fed the cocoa extract were mixed with plasma obtained from animals given water only. Conversely, plasma obtained from rats given the cocoa extract improved the resistance of erythrocytes obtained from rats given water only. These results show cocoa flavanols and procyanidins can provide membrane protective effects.
HensleyK, RobinsonKA, GabbitaSP, SalsmanS, FloydRA. Reactive oxygen species, cell signalling, and cell injury. Free Rad Biol Med28: 1456–1462, 2000.
2.
MortonLW, CaccettaRA-A, PuddeyIB, CroftKD. Chemistry and biological effects of dietary phenolic compounds: relevance to cardiovascular disease. Clin Exp Pharmacol Physiol27: 152–159, 2000.
3.
MorenaM, CristolJ, CanaudB. Why hemodialysis patients are in a prooxidant state: What could be done to correct the pro/antioxidant imbalance. Blood Purification18: 191–199, 2000.
4.
HalliwellB, GutteridgeJM, CrossCE. Free radicals, antioxidants, and human disease: Where are we now?J Lab Clin Med119: 598–620, 1992.
5.
NikiE, KomuroE, TakahashiM, UranoS, ItoE, TeraoK. Oxidative hemolysis of erythrocytes and its inhibition by free radical scavengers. J Biol Chem263: 19809–19814, 1988.
6.
Kris-EthertonPM, KeenCL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol13(1): 41–49, 2002.
7.
ChiuD, LubinB, ShohetS. Peroxidative reactions in red cell biology. In: PryorW, Ed. Free Radicals in Biology. New York: Academic Press, VolV: pp 115–160, 1982.
8.
PuppoA, HalliwellB. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Biochem J249: 185–190, 1988.
9.
MikiM, TamaiH, MinoM, YamamotoY, NikiE. Free-radical chain oxidation of rat red blood cells by molecular oxygen and its inhibition by α-tocopherol. Arch Biochem Biophys258: 373–380, 1987.
10.
MabileL, PiolotA, BouletL, FortinL-J, DoyleN, RodriquezC, DavignonJ, BlacheD, Lussier-CacanS. Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects. Am J Clin Nutr74: 449–456, 2001.
11.
MiddletonEJr., KandaswamiC, TheoharidesTC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev52: 673–751, 2000.
12.
RimmEB, AscherioA, GiovannucciE, SpiegelmanD, StampferMJ, WillettWC. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. J Am Med Assoc275: 447–451, 1996.
13.
LiuS, MansonJE, LeeI-M, ColeSR, HennekensCH, WillettWC, BuringJE. Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. Am J Clin Nutr72: 922–928, 2000.
14.
HertogMG, FeskensEJ, HollmanPC, KatanMB, KromhoutD. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet342: 1007–1011, 1993.
15.
HertogMG, KromhoutD, AravanisC, BlackburnH, BuzinaR, FidanzaF, GiampaoliS, JansenA, MenottiA, NedeljkovicS, Pek-karinenM, SimicBS, ToshimaH, FeskensEJ, HollmanPC, KatanMB. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med155: 381–386, 1995.
16.
KnektP, JarvineneR, ReunanenA, MaatelaJ. Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J312: 478–481, 1996.
17.
Rice-EvansC, NicholasJ, MolwellP, BramleyP, PridhamJ. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res22: 375–383, 1995.
18.
LotitoSB, Actis-GorettaL, RenartL, CaligiuriM, ReinD, SchmitzHH, SteinbergFM, KeenCL, FragaCG. Influence of oligomer chain length on the antioxidant activity of procyanidins. Biochem Biophys Res Commun276: 945–951, 2000.
19.
StonerG, MukhtarH. Polyphenols as cancer chemopreventive agents. J Cell Biochem22: 169–180, 1995.
20.
ReinD, PaglieroniTG, WunT, PearsonDA, SchmitzHH, GosselinR, KeenCL. Cocoa inhibits platelet activation and function. Am J Clin Nutr72: 30–35, 2000.
21.
FreedmanJE, ParkerCI, LiL, PerlmanJA, PreiB, IvanovV, DeakLR, IafratiMD, FoltsJD. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation103: 2792–2798, 2001.
22.
SchrammDD, WangJF, HoltRR, EnsunsaJL, GonsalvesJL, LazarusSL, SchmitzHH, GermanJB, KeenCL. Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr73: 36–40, 2001.
23.
WangJF, SchrammDD, HoltRR, EnsunsaJL, FragaCG, SchmitzHH, KeenCL. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr130: 2115S–2119S, 2000.
24.
DuffyS, KeaneyJJ, HolbrookM, GokceN, SwerdloffPL, FreiB, VitaJA. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation104: 151–156, 2001.
25.
HammerstoneJF, LazarusSA, MitchellAE, RuckerR, SchmitzHH. Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry. J Agric Food Chem47: 490–496, 1999.
26.
AdamsonGE, LazarusSA, MitchellAE, PriorRL, CaoG, JacobsPH, KremersBG, HammerstoneJF, RuckerRB, RitterKA, SchmitzHH. HPLC method for the quantification of procyanidins in cocoa and chocolate samples and correlation to total antioxidant capacity. J Agric Food Chem47: 4184–4188, 1999.
27.
WaterhouseAL, ShirleyJR, DonovanJL. Antioxidants in chocolate. Lancet348: 834, 1996.
28.
KondoK, HiranoR, MatsumotoA, IgarashiO, ItakuraH. Inhibition of LDL oxidation by cocoa. Lancet348: 1514, 1996.
29.
PearsonDA, SchmitzHH, LazarusSA, KeenCL. Inhibition of in vitro low-density lipoprotein oxidation by oligomeric procyanidins present in chocolate and cocoas. In: PackerL, Ed. Methods in Enzymology. New York: Academic Press, pp 350–360, 2001.
30.
ArteelGE, SiesH. Protection against peroxynitrite by cocoa polyphenol oligomers. FEBS Lett462: 167–170, 1999.
31.
ReinD, LotitoS, HoltRR, KeenCL, SchmitzHH, FragaCG. Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J Nutr130: 2109S–2114S, 2000.
32.
HatherillR, TillG, WardP. Mechanisms of oxidant-induced changes in erythrocytes. Agents Actions32: 351–358, 1991.
33.
RichelleM, TavazziI, EnslenM, OffordE. Plasma kinetics in man of epicatechin from black chocolate. Eur J Clin Nutr53: 22–26, 1999.
34.
HoltRR, LazarusSA, SullardsMC, ZhuQY, SchrammDD, HammerstoneJF, FragaCG, SchmitzH, KeenCL. Procyanidin dimer B2 (epicatechin-(4β-8)-epicatechin) in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr (in press) 2002.
35.
LisseE, Salim-HannaM, PascualC, del CastilloMD. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med18: 153–158, 1995.
36.
ZhuQY, HoltRR, LazarusSA, EnsunsaJL, HammerstoneJF, SchmitzHH, KeenCL. Stability of flavan-3-ols epicatechin and catechin and related dimeric procyanidins derived from cocoa. J Agric Food Chem50: 1700–1705, 2002.
37.
Rice-EvansC. Flavonoid antioxidants. Curr Med Chem8: 797–807, 2001.
38.
ArtsI, HollmanP, KromhoutD. Chocolate as a source of tea flavonoids. Lancet354: 488, 1999.
39.
LazarusSA, HammerstoneJF, SchmitzHH. Chocolate contains additional flavonoids not found in tea. Lancet354: 1825, 1999.
40.
MaY, StoneW, LeclairI. The effects of vitamin C and urate on the oxidation of human low-density lipoprotein. Proc Soc Exp Biol Med206: 53–59, 1994.
41.
TakahashiT, KamiyaT, HasegawaA, YokooY. Procyanidin oligomers selectively and intensively promote proliferation of mouse hair epithelial cells in vitro and activate hair follicle growth in vivo.J Invest Dermatol112: 310–316, 1999.
42.
TsuchiyaH. Stereospecificity in membrane effects of catechins. Chem Biol Interact134: 41–54, 2001.
43.
ZhuQY, HuangY, TsangD, ChenZY. Regeneration of α-tocopherol in human LDL by green tea catechins. J Agric Food Chem47: 2020–2025, 1999.
44.
HollmanP, KatanMB. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother51: 305–310, 1997.
45.
BabaS, OsakabeN, YasudaM, TakizawaT, NakamuraT, TeraoJ. Cocoa powder enhances the level of antioxidative activity in rat plasma. Br Med J84: 673–680, 2000.
46.
SpencerJP, ChaudryF, PannalaAS, SraiSK, DebnamE, Rice-EvansC. Decomposition of cocoa procyanidins in the gastric milieu. Biochem Biophys Res Commun272: 236–241, 2000.
